The Discounted Cash Flow (DCF) valuation of ADMA Biologics Inc (ADMA) is 22.34 USD. With the latest stock price at 19.88 USD, the upside of ADMA Biologics Inc based on DCF is 12.4%.
Based on the latest price of 19.88 USD and our DCF valuation, ADMA Biologics Inc (ADMA) is a buy. buying ADMA stocks now will result in a potential gain of 12.4%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.8% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 13.60 - 67.25 | 22.34 |
| Upside | -31.6% - 238.3% | 12.4% |